Buyer Indecision Is Your Real Competitor (and More Selling Feeds It)
When a proposal goes quiet, most founders blame a rival firm, a budget freeze, or a buyer who "wasn't serious." Matt Dixon and Ted McKenna studied 2.5 million sales conversations and found a different culprit: 56% of deals lost to no decision die because the buyer is too afraid to choose — and the instinctive response, selling harder, makes that fear worse.
Ask a founder why a promising deal went silent and you'll hear the same suspects every time. A competitor undercut us. The budget got pulled. The buyer was never serious. Each explanation has one thing in common: it points somewhere safe — away from the sales conversation itself.
But the evidence points back at the conversation. Matt Dixon and Ted McKenna ran the largest study of sales calls ever assembled — 2.5 million recorded conversations spanning industries and deal sizes — and what they found should change how every consultancy, agency, and coaching business handles a stalled proposal.
Of the deals that end in "no decision," 56% are not lost to the status quo. The buyer agrees something has to change. They believe your diagnosis. They want what you're offering. And then they freeze — not because they doubt the problem, but because they're terrified of choosing wrongly.
In other words: your most dangerous competitor isn't the firm across town. It's the fear sitting inside your buyer's head. And almost everything sellers instinctively do when a deal stalls feeds that fear instead of resolving it.
The Instinct That Backfires
Why Re-Pitching a Convinced Buyer Destroys Deals
Here's what most expertise-business founders do when a prospect goes quiet after a strong meeting: they sell harder. Another deck. A fresh case study. A sharpened proposal. A second walkthrough of the value proposition, just to be safe.
Dixon and McKenna have a name for this — relitigation — and a verdict on it: re-arguing the case for change to a buyer who has already accepted the case for change produces a negative effect 84% of the time. You are answering a question the buyer is no longer asking, and in doing so you signal that even you think the decision needs more deliberation.
The reason this instinct misfires is that it confuses two completely different buyer states. A status-quo buyer doesn't yet believe change is worth it; for them, more urgency-building, more gap analysis, and more teaching is the right medicine. An indecisive buyer is past all of that. They're convinced. What's blocking them is fear — of picking the wrong package, of committing before they've researched enough, of being the person whose name is attached to an initiative that flops.
Feeding an indecisive buyer more persuasion is like handing a drowning swimmer more water. They don't need another reason to act. They need help choosing — and nobody in the room is offering it.
Which brings us to the four most misread words in selling: "Let me think about it." It sounds like momentum. It is almost always a buyer quietly sinking into paralysis, where every passing day makes the decision feel heavier rather than clearer.
Triage Before Treatment
Match Your Move to the Specific Fear in the Room
Indecision isn't one condition. Dixon and McKenna's research breaks it into three distinct fears, and the cure for one actively worsens the others. Before you respond to a stall, diagnose which fear you're actually facing.
Fear one: too many doors. The buyer can't decide which option fits. Ironically, the three-tier proposal — a genuinely powerful pricing structure — can trigger this. Offered Premium, Standard, and Foundation, a decision-averse executive sees three chances to choose badly. The fix is to stop being neutral. Tell them which door you'd walk through and why, grounded in their own diagnostic data. The research puts a number on this kind of personal advocacy: telling a buyer what you would do in their position lifts win rates by 74%.
Fear two: the research spiral. The buyer wants to gather more information before committing, believing more inputs will shrink their risk. They almost never do — extra information tends to amplify indecision, not resolve it. The fix is to close the loop, honestly: between the assessment results and the benchmarks you've shared, this buyer already holds more diagnostic insight than most organizations ever have at the point of decision. Further study doesn't lower their risk. It only postpones their result.
Fear three: the failure scenario. The buyer keeps imagining the initiative going wrong — the spend wasted, their credibility dented. No amount of reassurance talks someone out of this fear. You have to structurally shrink the bet. Propose a phased start: one focus area, milestones agreed upfront, a six-week checkpoint, and a course-correction at no extra cost if the milestones slip. Now the buyer isn't making one giant irreversible call. They're making a small, recoverable one.
The sequencing matters as much as the moves themselves. Cap the research for a buyer who's actually afraid of failure, or push a single recommendation on a buyer who's drowning in unknowns, and you deepen the freeze. Triage first. Then treat.
Conviction Is a Service
The Recommendation Only You Can Make
Across all three fears, one factor moved the needle more than anything else in Dixon and McKenna's data: the seller's own confidence. Not rapport. Not discounting. Not the thickness of the case-study binder. The simple, declarative act of saying "this is what I recommend, and here is my reasoning" — and meaning it.
Most consultants and agency founders flinch at this. The accommodating, relationship-first seller has been trained to stay neutral: every option is a fine choice, it all depends on your priorities, we'll support whatever you decide. It sounds respectful. In practice it's an abdication — it hands the entire weight of the decision to the one person in the conversation who has already proven they can't carry it.
The Challenger move is the opposite. You've run the diagnostic. You've seen this pattern across the organizations you've served. So you say so: given the assessment data, the middle option attacks the highest-impact gap, shows measurable movement inside six weeks, and lays the groundwork for the bigger transformation later — and if it were your firm, that's where you'd start. A statement like that stakes your professional reputation on the outcome, and that's precisely why it works. An executive frozen by the fear of choosing wrong borrows courage from an expert willing to choose alongside them.
Reframe the stall itself. "Let me think about it" is not a request for time — it's an unspoken request for guidance from someone who can't bring themselves to ask for it. The founder who answers with a confident recommendation, a hard edge on the research phase, and a de-risked first step doesn't just rescue one deal. They become the advisor that buyer trusts with the next decision, and the one after that.
So stop treating the stall as a pause and start treating it as a symptom. Identify which of the three fears is doing the talking, answer that fear specifically, and walk your buyer across a line they genuinely want to cross.